This is a Study to Determine the Effect of Multiple Doses of an Investigational Drug, Taken by Mouth, in People With Narcolepsy-cataplexy. Accepting Both Males and Females Ages of 18 Years to 55 Years. This Study Will be Conducted in the US and Will Require Approximately 13 Weeks Participation.
Clinical trial NCT05015673 · COMPLETED
Trial details
- NCT number
- NCT05015673
- Sponsor
- Otsuka Pharmaceutical Development & Commercialization, Inc.
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2014-06-05
- Primary completion
- 2015-05-26
- Enrollment
- 18
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.